Peer Exchange

AJMCtv Peer Exchange provides a multi-stakeholder perspective on important issues facing managed care professionals in the evolving healthcare landscape.
Oncology Stakeholders Summit, Spring 2016: Evaluating the Quality of Evidence Used for Developing Value Frameworks

As innovation continues to boom in the oncology market, Bruce A. Feinberg, DO; Alan Balch, PhD; and Michael Kolodziej, MD, discuss unmet needs when measuring a drug’s value, which affects payer coverage for a drug. The panelists also describe the potential effectiveness of patient feedback when determining a product’s value in the market.
Oncology Stakeholders Summit, Spring 2016: Rightsizing Drug Distribution to Improve Value

James Gilroy and Ted Okon, MBA, discuss innovation in the oncology market, and remark on its effects on drug pricing and availability to the patient. Value needs to be measured for all parties involved in the drug distribution process, concludes Okon.
More on Oncology Stakeholders Summit >>>
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium
HF Compendium